Related Experiment Video
Updated: May 23, 2026

Reverse Yeast Two-hybrid System to Identify Mammalian Nuclear Receptor Residues that Interact with Ligands and/or Antagonists
Published on: November 15, 2013
Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation
Paul M Musille1, Manish Pathak1, Janelle L Lauer2
1Department of Biochemistry, Emory University School of Medicine, Atlanta, GA 30322, USA.
Abstract:
The human nuclear receptor liver receptor homolog-1 (LRH-1) has an important role in controlling lipid and cholesterol homeostasis and is a potential target for the treatment of diabetes and hepatic diseases. LRH-1 is known to bind phospholipids, but the role of phospholipids in controlling LRH-1 activation remains highly debated. Here we describe the structure of both apo LRH-1 and LRH-1 in complex with the antidiabetic phospholipid dilauroylphosphatidylcholine (DLPC). Together with hydrogen-deuterium exchange MS and functional data, our studies show that DLPC binding is a dynamic process that alters co-regulator selectivity. We show that the lipid-free receptor undergoes previously unrecognized structural fluctuations, allowing it to interact with widely expressed co-repressors. These observations enhance our understanding of LRH-1 regulation and highlight its importance as a new therapeutic target for controlling diabetes.
Insights
The liver receptor homolog-1 (LRH-1) protein
Area of Science:
- Biochemistry and molecular biology
- Endocrinology
- Metabolic diseases
Background:
- The nuclear receptor liver receptor homolog-1 (LRH-1) plays a key role in regulating lipid and cholesterol metabolism.
- LRH-1 is a potential therapeutic target for diabetes and liver diseases.
- The precise role of phospholipids in LRH-1 activation is not fully understood.
Purpose of the Study:
- To elucidate the structural and dynamic mechanisms of LRH-1 activation by phospholipids.
- To investigate the interaction between LRH-1 and the antidiabetic phospholipid dilauroylphosphatidylcholine (DLPC).
Main Methods:
- X-ray crystallography to determine the structures of apo LRH-1 and LRH-1-DLPC complex.
- Hydrogen-deuterium exchange mass spectrometry (HDX-MS) to study protein dynamics.
- Functional assays to assess co-regulator binding and activity.
Main Results:
- The crystal structure of LRH-1 in complex with DLPC was determined.
- DLPC binding was shown to be a dynamic process that modulates LRH-1 conformation.
- Lipid-free LRH-1 exhibits structural fluctuations enabling interaction with co-repressors.
- DLPC binding alters co-regulator selectivity, favoring co-activators.
Conclusions:
- Phospholipid binding, specifically DLPC, is crucial for regulating LRH-1 activity and co-regulator interaction.
- Understanding LRH-1's dynamic structural changes upon lipid binding provides new insights into its role in metabolic homeostasis.
- These findings reinforce LRH-1 as a promising therapeutic target for managing diabetes and related hepatic conditions.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting
Cell Specific Gene Expression
Insulin: The Receptor and Signaling Pathways
Signal Transduction: Overview
Typically, signal transduction involves three...
Co-activators and Co-repressors
